A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma.
The Journal of pediatrics · 2001-09-01 · Randomised trial
Abstract
This study was conducted to investigate whether a single dose of nebulized budesonide effectively decreased airway inflammation as demonstrated by exhaled nitric oxide (eNO) levels. A single dose of nebulized budesonide, but not nebulized terbutaline, rapidly decreased eNO levels in 6 hours. The decrease in eNO levels induced by nebulized budesonide was correlated to an increase in peak expiratory flow rate.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Children · Inhaled corticosteroids · Respiratory drugs · Terbutaline
Related articles
- Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. (J Asthma, 2008)
- The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. (Ann Allergy Asthma Immunol, 2001)
- Effect of budesonide on hospitalization rates among children with acute asthma attending paediatric emergency department: a systematic review and meta-analysis. (World J Pediatr, 2021)
- Adding nebulized corticosteroids to systemic corticosteroids for acute asthma in children: A systematic review with meta-analysis. (Pediatr Pulmonol, 2020)
- Nebulized Inhaled Corticosteroids in Asthma Treatment in Children 5 Years or Younger: A Systematic Review and Global Expert Analysis. (J Allergy Clin Immunol Pract, 2020)
- Effectiveness of inhaled corticosteroids in the treatment of acute asthma in children in the emergency department: a meta-analysis. (Ann Med, 2014)